Clinical Trial Update: Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports a Phase 2 study evaluating inhaled tacrolimus as an add-on to inhaled corticosteroids and long-acting beta-agonists in mod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Asthma, Bronchial, Bronchial Asthma | Phase 2 | Status: COMPLETED